- Home
- DXR vs HERZ Comparison
DXR vs HERZ Comparison
Compare DXR & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- HERZ
- Stock Information
- Founded
- DXR 1970
- HERZ N/A
- Country
- DXR United States
- HERZ United States
- Employees
- DXR N/A
- HERZ N/A
- Industry
- DXR Medical/Dental Instruments
- HERZ Investment Managers
- Sector
- DXR Health Care
- HERZ Finance
- Exchange
- DXR Nasdaq
- HERZ Nasdaq
- Market Cap
- DXR 46.9M
- HERZ 38.8M
- IPO Year
- DXR N/A
- HERZ N/A
- Fundamental
- Price
- DXR $11.41
- HERZ $2.44
- Analyst Decision
- DXR Strong Buy
- HERZ
- Analyst Count
- DXR 1
- HERZ 0
- Target Price
- DXR $25.00
- HERZ N/A
- AVG Volume (30 Days)
- DXR 7.9K
- HERZ N/A
- Earning Date
- DXR 01-01-0001
- HERZ N/A
- Dividend Yield
- DXR N/A
- HERZ N/A
- EPS Growth
- DXR 3.46
- HERZ N/A
- EPS
- DXR 0.36
- HERZ N/A
- Revenue
- DXR $66,306.00
- HERZ N/A
- Revenue This Year
- DXR N/A
- HERZ N/A
- Revenue Next Year
- DXR N/A
- HERZ N/A
- P/E Ratio
- DXR $32.33
- HERZ N/A
- Revenue Growth
- DXR N/A
- HERZ N/A
- 52 Week Low
- DXR $6.55
- HERZ N/A
- 52 Week High
- DXR $11.70
- HERZ N/A
- Technical
- Relative Strength Index (RSI)
- DXR 56.84
- HERZ 47.87
- Support Level
- DXR $11.10
- HERZ $2.42
- Resistance Level
- DXR $11.70
- HERZ $2.59
- Average True Range (ATR)
- DXR 0.50
- HERZ 0.08
- MACD
- DXR 0.00
- HERZ -0.01
- Stochastic Oscillator
- DXR 82.65
- HERZ 25.10
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About HERZ Herzfeld Credit Income Fund Inc. Common Stock
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.